Brainstem Injury in Pediatric Patients With Posterior Fossa Tumors Treated With Proton Beam Therapy and Associated Dosimetric Factors

被引:68
作者
Gentile, Michelle S. [1 ]
Yeap, Beow Y. [2 ]
Paganetti, Harald [1 ]
Goebel, Claire P. [1 ]
Gaudet, Dillon E. [1 ]
Gallotto, Sara L. [1 ]
Weyman, Elizabeth A. [1 ]
Morgan, Michael L. [1 ]
MacDonald, Shannon M. [1 ]
Giantsoudi, Drosoula [1 ]
Adams, Judith [1 ]
Tarbell, Nancy J. [1 ]
Kooy, Hanne [1 ]
Yock, Torunn I. [1 ]
机构
[1] Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2018年 / 100卷 / 03期
关键词
CENTRAL-NERVOUS-SYSTEM; CEREBRAL RADIATION NECROSIS; HIGH-DOSE CHEMOTHERAPY; CLINICAL-OUTCOMES; IMAGING CHANGES; CHILDREN; RADIOTHERAPY; MEDULLOBLASTOMA; EPENDYMOMA; PARAMETERS;
D O I
10.1016/j.ijrobp.2017.11.026
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Proton radiation therapy is commonly used in young children with brain tumors for its potential to reduce late effects. However, some proton series report higher rates of brainstem injury (0%-16%) than most photon series (2.2%-8.6%). We report the incidence of brainstem injury and a risk factor analysis in pediatric patients with posterior fossa primary tumors treated with proton radiation therapy at our institution. Methods and Materials: The study included 216 consecutive patients treated between 2000 and 2015. Dosimetry was available for all but 4 patients. Grade 2 to 5 late brainstem toxicity was assessed by the National Cancer Institute Common Terminology Criteria for Adverse Events version 4.0. Results: The histologies include medulloblastoma (n=154, 71.3%), ependymoma (n=56, 25.9%), and atypical teratoid rhabdoid tumor (n=6, 2.8%). The median age at irradiation was 6.6 years (range, 0.5-23.1 years); median dose, 54 gray relative biological effectiveness (Gy RBE) (range, 46.8-59.4 Gy RBE); and median follow-up period, 4.2 years (range, 0.1-15.3 years) among 198 survivors. Of the patients, 83.3% received chemotherapy; 70.4% achieved gross total resection. The crude rate of injury was 2.3% in all patients, 1.9% in those with medulloblastoma, 3.6% in those with ependymoma, and 0% in those with atypical teratoid rhabdoid tumor. The 5-year cumulative incidence of injury was 2.0% (95% confidence interval, 0.7%-4.8%). The median brainstem dose (minimum dose received by 50% of brainstem) in the whole cohort was 53.6 Gy RBE (range, 16.5-56.8 Gy RBE); maximum point dose within the brainstem (D-max), 55.2 Gy RBE (range, 48.4-60.5 Gy RBE); and mean dose, 50.4 Gy RBE (range, 21.1-56.7 Gy RBE). In the 5 patients with injury, the median minimum dose received by 50% of the brainstem was 54.6 Gy RBE (range, 50.2-55.1 Gy RBE); D-max, 56.2 Gy RBE (range, 55.0-57.1 Gy RBE); mean dose, 51.3 Gy RBE (range, 45.4-54.4 Gy RBE); and median volume of the brainstem receiving >= 55 Gy RBE (V-55), 27.4% (range, 0%-59.4%). Of the 5 patients with injury, 4 had a brainstem D-max in the highest quartile (>= 55.8 Gy RBE, P=.016) and a V-55 in the highest tertile (>6.0%) of the cohort distribution (P=.047). Of the 5 patients with injury, 3 were aged >6 years (age range, 4.1-22.8 years), and 4 of 5 patients received chemotherapy and achieved gross total resection. Conclusions: The incidence of injury in pediatric patients with posterior fossa tumors is consistent with previous reports in the photon setting. Our data suggest that when D-max and V-55 are kept <55.8 Gy RBE and <= 6.0%, respectively, the 5-year rate of radiation brainstem injury would be <2%. (C) 2017 Elsevier Inc. All rights reserved.
引用
收藏
页码:719 / 729
页数:11
相关论文
共 29 条
[1]   Pencil beam scanning proton therapy for pediatric intracranial ependymoma [J].
Ares, Carmen ;
Albertini, Francesca ;
Frei-Welte, Martina ;
Bolsi, Alessandra ;
Grotzer, Michael A. ;
Goitein, Gudrun ;
Weber, Damien C. .
JOURNAL OF NEURO-ONCOLOGY, 2016, 128 (01) :137-145
[2]   Challenges With the Diagnosis and Treatment of Cerebral Radiation Necrosis [J].
Chao, Samuel T. ;
Ahluwalia, Manmeet S. ;
Barnett, Gene H. ;
Stevens, Glen H. J. ;
Murphy, Erin S. ;
Stockham, Abigail L. ;
Shiue, Kevin ;
Suh, John H. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (03) :449-457
[3]   Intensive Multimodality Treatment for Children With Newly Diagnosed CNS Atypical Teratoid Rhabdoid Tumor [J].
Chi, Susan N. ;
Zimmerman, Mary Ann ;
Yao, Xiaopan ;
Cohen, Kenneth J. ;
Burger, Peter ;
Biegel, Jaclyn A. ;
Rorke-Adams, Lucy B. ;
Fisher, Michael J. ;
Janss, Anna ;
Mazewski, Claire ;
Goldman, Stewart ;
Manley, Peter E. ;
Bowers, Daniel C. ;
Bendel, Anne ;
Rubin, Joshua ;
Turner, Christopher D. ;
Marcus, Karen J. ;
Goumnerova, Liliana ;
Ullrich, Nicole J. ;
Kieran, Mark W. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (03) :385-389
[4]   Endocrine outcomes with proton and photon radiotherapy for standard risk medulloblastoma [J].
Eaton, Bree R. ;
Esiashvili, Natia ;
Kim, Sungjin ;
Patterson, Briana ;
Weyman, Elizabeth A. ;
Thornton, Lauren T. ;
Mazewski, Claire ;
MacDonald, Tobey J. ;
Ebb, David ;
MacDonald, Shannon M. ;
Tarbell, Nancy J. ;
Yock, Torunn I. .
NEURO-ONCOLOGY, 2016, 18 (06) :881-887
[5]   Assessment of the Treatment Approach and Survival Outcomes in a Modern Cohort of Patients With Atypical Teratoid Rhabdoid Tumors Using the National Cancer Database [J].
Fischer-Valuck, Benjamin W. ;
Chen, Ishita ;
Srivastava, Amar J. ;
Floberg, John M. ;
Rao, Yuan James ;
King, Allison A. ;
Shinohara, Eric T. ;
Perkins, Stephanie M. .
CANCER, 2017, 123 (04) :682-687
[6]   White matter lesions detected by magnetic resonance imaging after radiotherapy and high-dose chemotherapy in children with medulloblastoma or primitive neuroectodermal tumor [J].
Fouladi, M ;
Chintagumpala, M ;
Laningham, FH ;
Ashley, D ;
Kellie, SJ ;
Langston, JW ;
McCluggage, CW ;
Woo, S ;
Kocak, M ;
Krull, K ;
Kun, LE ;
Mulhern, RK ;
Gajjar, A .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (22) :4551-4560
[7]   Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial [J].
Gajjar, Amar ;
Chintagumpala, Murali ;
Ashley, David ;
Kellie, Stewart ;
Kun, Larry E. ;
Merchant, Thomas E. ;
Woo, Shaio ;
Wheeler, Greg ;
Ahern, Valerie ;
Krasin, Matthew J. ;
Fouladi, Maryam ;
Broniscer, Alberto ;
Krance, Robert ;
Hale, Gregory A. ;
Stewart, Clinton F. ;
Dauser, Robert ;
Sanford, Robert A. ;
Fuller, Christine ;
Lau, Ching ;
Boyett, James M. ;
Wallace, Dana ;
Gilbertson, Richard J. .
LANCET ONCOLOGY, 2006, 7 (10) :813-820
[8]   Proton Treatment Techniques for Posterior Fossa Tumors: Consequences for Linear Energy Transfer and Dose-Volume Parameters for the Brainstem and Organs at Risk [J].
Giantsoudi, Drosoula ;
Adams, Judith ;
MacDonald, Shannon M. ;
Paganetti, Harald .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 97 (02) :401-410
[9]   Incidence of CNS Injury for a Cohort of 111 Patients Treated With Proton Therapy for Medulloblastoma: LET and RBE Associations for Areas of Injury [J].
Giantsoudi, Drosoula ;
Sethi, Roshan V. ;
Yeap, Beow Y. ;
Eaton, Bree R. ;
Ebb, David H. ;
Caruso, Paul A. ;
Rapalino, Otto ;
Chen, Yen-Lin E. ;
Adams, Judith A. ;
Yock, Torunn I. ;
Tarbell, Nancy J. ;
Paganetti, Harald ;
MacDonald, Shannon M. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 95 (01) :287-296
[10]   Cerebral radiation necrosis [J].
Giglio, P ;
Gilbert, MR .
NEUROLOGIST, 2003, 9 (04) :180-188